EA200600079A1 - Способ удаления трифенилметильной защитной группы - Google Patents

Способ удаления трифенилметильной защитной группы

Info

Publication number
EA200600079A1
EA200600079A1 EA200600079A EA200600079A EA200600079A1 EA 200600079 A1 EA200600079 A1 EA 200600079A1 EA 200600079 A EA200600079 A EA 200600079A EA 200600079 A EA200600079 A EA 200600079A EA 200600079 A1 EA200600079 A1 EA 200600079A1
Authority
EA
Eurasian Patent Office
Prior art keywords
sup
tripenilmethil
removal
protective group
ring
Prior art date
Application number
EA200600079A
Other languages
English (en)
Other versions
EA011507B1 (ru
Inventor
Станислав Радл
Ян Стах
Ондрей Клецан
Original Assignee
Зентива А.С.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CZ20032319A external-priority patent/CZ297016B6/cs
Priority claimed from CZ20040733A external-priority patent/CZ298329B6/cs
Application filed by Зентива А.С. filed Critical Зентива А.С.
Publication of EA200600079A1 publication Critical patent/EA200600079A1/ru
Publication of EA011507B1 publication Critical patent/EA011507B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Encapsulation Of And Coatings For Semiconductor Or Solid State Devices (AREA)
  • Dicing (AREA)
  • Peptides Or Proteins (AREA)
  • Manufacture Of Electron Tubes, Discharge Lamp Vessels, Lead-In Wires, And The Like (AREA)

Abstract

Способ удаления трифенилметильной защитной группы из 1-трифенилметил-5-(4'-замещенный метил-1,1'-бифенил-2-ил)-1Н-тетразолов общей формулы I, где R представляет собой группы нижеприведенных формул и где R, Rи Rмогут представлять собой Н, галоген, неразветвленный или разветвленный С1-С5 алкил, С1-С5 гидроксиалкил, С1-С5 алкокси, С1-С5 алкоксиметил или бензил, или где Rи Rмогут образовывать вместе насыщенное или ненасыщенное С5-С7 кольцо, возможно незамещенное или замещенное ароматическое кольцо, осуществляют путем сольволиза в простом безводном С1-С5 спирте в нейтральной или слабощелочной среде. Этот способ пригоден для получения лекарственных средств, таких как калиевая соль лосартана, ирбесартан, либо вальсартан или кандесартан цилексетил.
EA200600079A 2003-08-27 2004-08-26 Способ получения калиевой соли лосартана EA011507B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CZ20032319A CZ297016B6 (cs) 2003-08-27 2003-08-27 Zpusob odstranování trifenylmethanové chránicí skupiny z 1-trityl-5-(4'-subst. aminomethyl-1,1' -bifenyl-2-yl)-1H-tetrazolu a zpusob výroby draselné soli losartanu, irbesartanu a valsartanu s jeho pouzitím
CZ20040733A CZ298329B6 (cs) 2004-06-16 2004-06-16 Zpusob výroby 1-(cyklohexyloxykarbonyloxy)ethyl-2-ethoxy-1-[[2´-(1H-tetrazol-5-yl)bifenyl-4-yl]methyl]benzimidazol-7-karboxylátu (candesartan cilexetilu)
PCT/CZ2004/000051 WO2005021535A2 (en) 2003-08-27 2004-08-26 A method of removing the triphenylmethane protecting group

Publications (2)

Publication Number Publication Date
EA200600079A1 true EA200600079A1 (ru) 2006-08-25
EA011507B1 EA011507B1 (ru) 2009-04-28

Family

ID=34276338

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200600079A EA011507B1 (ru) 2003-08-27 2004-08-26 Способ получения калиевой соли лосартана

Country Status (13)

Country Link
US (1) US20060287537A1 (ru)
EP (1) EP1658281B1 (ru)
AT (1) ATE482950T1 (ru)
CA (1) CA2536781A1 (ru)
DE (1) DE602004029373D1 (ru)
EA (1) EA011507B1 (ru)
ES (1) ES2348300T3 (ru)
HR (1) HRP20060119A2 (ru)
PL (2) PL379886A1 (ru)
PT (1) PT1658281E (ru)
RS (1) RS20060125A (ru)
SK (1) SK50142006A3 (ru)
WO (1) WO2005021535A2 (ru)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7692023B2 (en) 2004-02-11 2010-04-06 Teva Pharmaceutical Industries Ltd. Candesartan cilexetil polymorphs
EP1812423A1 (en) * 2004-11-11 2007-08-01 LEK Pharmaceuticals D.D. Process for the synthesis of tetrazoles
EP1661891A1 (en) * 2004-11-30 2006-05-31 KRKA, D.D., Novo Mesto A process for the synthesis of valsartan
SI22127A (sl) 2005-10-07 2007-04-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Postopek za pripravo kandesartan cileksetila
CZ299902B6 (cs) * 2005-10-27 2008-12-29 Zentiva, A. S Zpusob odstranování trifenylmethanové chránicí skupiny u prekurzoru antihypertenzních léciv
WO2008018843A1 (en) * 2006-08-08 2008-02-14 Ulkar Kimya Sanayi Ve Ticaret As Process for producing useful salts form of biphenyl-tetrazole compounds
US8492577B2 (en) 2008-04-07 2013-07-23 Hetero Research Foundation Process for preparation of valsartan intermediate
WO2010046804A2 (en) * 2008-10-21 2010-04-29 Alembic Limited A process for preparation of losartan potassium form i
EP2432777A1 (en) 2009-05-20 2012-03-28 Ranbaxy Laboratories Limited Process for the preparation of olmesartan medoxomil
WO2011080684A1 (en) 2009-12-31 2011-07-07 Ranbaxy Laboratories Limited Process for the preparation of candesartan cilexetil
WO2011092666A1 (en) 2010-01-29 2011-08-04 Ranbaxy Laboratories Limited An improved process for the preparation of candesartan cilexetil, polymorphic forms of n-trityl candesartan and their uses thereof
CN103012382B (zh) * 2012-12-05 2016-10-05 迪沙药业集团有限公司 一种奥美沙坦酯的制备方法
US10323029B2 (en) 2014-09-29 2019-06-18 The Scripps Research Institute Sphinogosine-1-phosphate receptor modulators for treatment of cardiopulmonary disorders
US11327065B1 (en) * 2021-08-27 2022-05-10 Jubilant Generics Limited Preparation of angiotensin receptor blockers or pharmaceutically acceptable salts thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0443983T3 (da) * 1990-02-19 1996-03-18 Ciba Geigy Ag Acrylforbindelser
US5270317A (en) * 1990-03-20 1993-12-14 Elf Sanofi N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present
US5196444A (en) * 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
AT395853B (de) * 1991-01-31 1993-03-25 Chem Pharm Forsch Gmbh Neue imidazolderivate, verfahren zu ihrer herstellung und ihre verwendung
US5281604A (en) * 1993-04-23 1994-01-25 American Cyanamid Company Angiotensin II receptor blocking 2,3,6-substituted quinazolinones
SK722003A3 (en) * 2001-05-18 2003-12-02 Aurobindo Pharma Ltd Process for the crystallization of losartan potassium

Also Published As

Publication number Publication date
WO2005021535A2 (en) 2005-03-10
RS20060125A (en) 2008-06-05
EA011507B1 (ru) 2009-04-28
SK50142006A3 (sk) 2006-05-04
EP1658281B1 (en) 2010-09-29
DE602004029373D1 (de) 2010-11-11
ATE482950T1 (de) 2010-10-15
WO2005021535A3 (en) 2005-06-09
US20060287537A1 (en) 2006-12-21
PT1658281E (pt) 2010-10-12
HRP20060119A2 (en) 2006-05-31
CA2536781A1 (en) 2005-03-10
ES2348300T3 (es) 2010-12-02
PL379886A1 (pl) 2006-11-27
PL1658281T3 (pl) 2010-12-31
EP1658281A2 (en) 2006-05-24

Similar Documents

Publication Publication Date Title
EA200600079A1 (ru) Способ удаления трифенилметильной защитной группы
AR082825A2 (es) Inhibidores heterociclicos nitrogenados de mek, composiciones farmaceuticas que los contienen, metodos para prepararlos y uso de los mismos para el tratamiento de trastornos hiperproliferativos o inflamatorios
CO5601030A2 (es) Derivados de quinolinona/benzoxazinona y usos de los mismos
MA31574B1 (fr) Dérivés de pyrazole et leur utilisation comme inhibiteurs de raf
CL2011001586A1 (es) Metodo que comprende una composicion que contiene sulfoximida de 6-haloalquilpiridin-3-il-alquilo n-sustituida; composicion comprendiendo una mezcla estereoisomera de dicha sulfoximida en una formulacion farmaceutica acuosa.
RS53348B (en) PROCEDURE FOR THE PREPARATION OF 3-SUBSTITUTED 2-AMINO-5-HALOBENZAMIDES
RS54047B1 (en) PROCEDURE FOR OBTAINING 4-OXOCHINOLINE COMPOUNDS
ECSP066967A (es) Derivados de tetrahidroquinolina y un procedimiento para preparar los mismos
NO20085269L (no) 2-tioksantinderivater som fungerer som MPO-inhibitorer
AR057023A1 (es) Compuestos heterociclicos con propiedades inhibidoras de hiv-integrasa
AR048669A1 (es) Derivados biciclicos de bisamida
SV2010003483A (es) Pirimidinas biciclicas fusionadas
AR057626A1 (es) Derivados de pirido pirazo y pirimido- pirimidina y su uso como inhibidores de mtor
UY29393A1 (es) Nuevos derivados de amidas, sales farmacéuticas aceptables, composiciones que los contienen, procedimientos de preparación y aplicaciones.
AR066020A1 (es) Derivados de imidazolidin-2, 4-diona, una composicion farmaceutica que los comprende y su uso en la preparacion de un medicamento para el tratamiento de enfermedades mediadas por la inhibicion de parp-1.
MA30821B1 (fr) Derives de pyrazoline utiles comme antagonistes des recepteurs de mineralocorticoïdes
UY31388A1 (es) Método para la producción de 2´-desoxi-5-azacitidina (decitabina)
EA201170595A1 (ru) ПРОИЗВОДНОЕ ФЕНАНТРОИНДОЛИЗИДИНА И ИНГИБИТОР NFkB, СОДЕРЖАЩИЙ ЕГО В КАЧЕСТВЕ АКТИВНОГО ИНГРЕДИЕНТА
ECSP088700A (es) Acidos 4-fenil-tiazol-5-carboxilicos y amidas de acidos 4-fenil-tiazol-5-carboxilicos como inhibidores de la plk1
CO6321266A2 (es) Inhibidores limk2 compuestos de los cuales estan hechos y metodologia de uso
AR078142A1 (es) Compuestos inhibidores heteroarilicos biciclicos de pde4, las composiciones farmaceuticas que los contienen y el uso de los mismos para la preparacion de medicamentos.
PE20091359A1 (es) Proceso de preparacion de compuestos organicos intermediarios de inhibidores de renina
AR063576A1 (es) Arilsulfonil- pirrolidinas como inhibidores 5-ht6
ECSP045420A (es) Derivados de benzoxazina como moduladores 5-ht6 y usos de los mismos
TW200732707A (en) Optical filter

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): KZ